PURDUE (US) — A new biosensor detects tiny concentrations of glucose in saliva, tears, and urine—and may ultimately eliminate or reduce the need for pinpricks for diabetes testing.
Researchers say the sensor could be manufactured at low cost because it doesn’t require many processing steps to produce.
“It’s an inherently non-invasive way to estimate glucose content in the body,” says Jonathan Claussen, a former Purdue University doctoral student and now a research scientist at the US Naval Research Laboratory.
“Because it can detect glucose in the saliva and tears, it’s a platform that might eventually help to eliminate or reduce the frequency of using pinpricks for diabetes testing. We are proving its functionality.”
Claussen and Purdue doctoral student Anurag Kumar led the project, working with Timothy Fisher, professor of mechanical engineering; D. Marshall Porterfield, professor of agricultural and biological engineering; and other researchers at the university’s Birck Nanotechnology Center.
Findings are detailed in a research paper being published this week in the journal Advanced Functional Materials.
“Most sensors typically measure glucose in blood,” Claussen says. “Many in the literature aren’t able to detect glucose in tears and the saliva. What’s unique is that we can sense in all four different human serums: the saliva, blood, tears, and urine. And that hasn’t been shown before.”
The sensor has three main parts: layers of nanosheets resembling tiny rose petals made of graphene, a single-atom-thick film of carbon, platinum nanoparticles, and the enzyme glucose oxidase.
Each petal contains a few layers of stacked graphene. The edges of the petals have dangling, incomplete chemical bonds, defects where platinum nanoparticles can attach. Electrodes are formed by combining the nanosheet petals and platinum nanoparticles. Then the glucose oxidase attaches to the platinum nanoparticles. The enzyme converts glucose to peroxide, which generates a signal on the electrode.
“Typically, when you want to make a nanostructured biosensor you have to use a lot of processing steps before you reach the final biosensor product,” says Kumar.
“That involves lithography, chemical processing, etching and other steps. The good thing about these petals is that they can be grown on just about any surface, and we don’t need to use any of these steps, so it could be ideal for commercialization.”
In addition to diabetes testing, the technology might be used for sensing a variety of chemical compounds to test for other medical conditions.
“Because we used the enzyme glucose oxidase in this work, it’s geared for diabetes,” Claussen says. “But we could just swap out that enzyme with, for example, glutemate oxidase, to measure the neurotransmitter glutamate to test for Parkinson’s and Alzheimer’s, or ethanol oxidase to monitor alcohol levels for a breathalyzer. It’s very versatile, fast, and portable.”
The technology is able to detect glucose in concentrations as low as 0.3 micromolar, far more sensitive than other electrochemical biosensors based on graphene or graphite, carbon nanotubes and metallic nanoparticles
“These are the first findings to report such a low sensing limit and, at the same time, such a wide sensing range,” Claussen says.
The sensor is able to distinguish between glucose and signals from other compounds that often cause interference in sensors: uric acid, ascorbic acid and acetaminophen, which are commonly found in the blood. Unlike glucose, those compounds are said to be electroactive, which means they generate an electrical signal without the presence of an enzyme.
Glucose by itself doesn’t generate a signal but must first react with the enzyme glucose oxidase. Glucose oxidase is used in commercial diabetes test strips for conventional diabetes meters that measure glucose with a finger pinprick.
Source: Purdue University